Urothelial differentiation and bladder cancer

Advances in Experimental Medicine and Biology

Volumn 462, Issue , 1999, Pages 437-448

  Liebert, M ^a   Gebhardt, D ^a   Wood, C ^a   Chen, I L L ^a   Ellard, J ^a   Amancio, D ^a   Grossman, H B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BLOOD GROUP ANTIGEN; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; INTEGRIN; TUMOR MARKER; UROPLAKIN; UVOMORULIN;

BLADDER CANCER; BLADDER CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; DESMOSOME; HUMAN; PRIORITY JOURNAL; UROTHELIUM;

EID: 0033281573     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4737-2_34     Document Type: Conference Paper

References (60)

1. A genetic model for colorectal tumorigenesis
2. Tumor suppressor genes: New prospects for cancer research
3. Hereditary cancer, oncogenes and antioncogenes
4. How many human cancer genes?
5. Carcinogenesis and cancer: Different perspectives on the same disease
6. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis
7. The role of differentiation in the suppression of malignancy
8. Cancer statistics, 1998
9. Biology and management of bladder cancer
10. Squamous cell differentiation markers in normal, premalignant, and malignant epithelium: Effects of retinoids
11. Some histochemical observations on transitional epithelium of man
12. Pathology and staging of bladder cancer
13. Cell replacement and differentiation in transitional epithelium: A histological and autoradiographic study of the guinea-pig bladder and ureter
14. Growth fraction of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67
15. Cell proliferation of transtional cell bladder tumors determined by PCNA/cyclin immunostaining and its prognostic value
16. Actin and actin-binding proteins. A critical evaluation of mechanisms and functions
17. G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials
18. Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis
19. Gelsolin: A candidate for suppressor of human bladder cancer
20. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines
21. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies
22. Cytokeratin 20 expression by non-invasive transitional cell carcinomas: Potential for distinguishing recurrent from non-recurrent disease
23. Cytokeratin 20 as an objective marker of urothelial dysplasia
24. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
25. Expression of mal is associated with urothelial differentiation in vitro: Identification by differential display reverse transcriptase polymerase chain reaction
26. Structure of the human desmoplakins
27. Biology of Disease. Desmosomal Proteins: New markers for identification and classification of tumors
28. Correlation between numbers of desmosomes and the aggressiveness of transitional cell carcinoma in human urinary bladder
29. Desmoplakin expression and distribution in cultured rat bladder epithelial cells of varying tumorigenic potential
30. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors
31. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
32. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
33. Integrins: Versatility, modulation and signalling in cell adhesion
34. Expression of the VLA β1 integrin family in bladder cancer
35. Expression and in vitro regulation of integrins by normal human urothelial cells
36. Loss of co-localization of α6β4integrin and collagen VII in bladder cancer
37. Regulation of keratinocytes intercellular junction organization and epidermal morphogenesis by E-cadherin
38. The role of integrins α2β1 and α3β1 in cell-cell and cell-substrate adhesion of human epidermal cells
39. Blood group antigens in normal and neoplastic urothelium
40. Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotope of the initial tumor
41. Altered reactivity for ABH antigens in transitional cell carcinomas of the urinary bladder
42. Activity of human blood group ABO, Se, H, Le and X gene-encoded glycosyltransferaces in normal and malignant urothelium
43. The asymmetric unit membranes of the epithelium of the urinary bladder of the rat
44. Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation
45. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers or metastatic transitional cell carcinomas
46. Epidermal growth factor and its receptor: Markers of - and targets for - chemoprevention of bladder cancer
47. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer
48. The epidermal growth factor receptor and the prognosis of bladder cancer
49. Evaluation of epidermal growth factor receptors in bladder tumors
50. Expression of mutant p53, c-erb-B2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder
51. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
52. Distribution and cloning of eukaryotic mRNAs by means of differential display; refinements and optimization
53. The potential roles of nm23 in cancer metastasis and cellular differentiation
54. Gene structure, promoter activity, chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family
55. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder
56. Cancer chemoprevention
57. Differentiation, differentiation/gene therapy and cancer
58. Comparison of antigen expression on normal urothelial cells in tissue section and tissue culture